Clinical Trials Logo

Filter by:
NCT ID: NCT01075126 Withdrawn - Bipolar Disorder Clinical Trials

Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder

Start date: December 2006
Phase: Phase 4
Study type: Interventional

It is hypothesized that Depakote will be better tolerated then lithium in treating African Americans with bipolar disorder.

NCT ID: NCT01074918 Withdrawn - Hypertension Clinical Trials

Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Start date: September 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to compare the effects of Potassium Magnesium Citrate to Potassium Chloride on blood pressure among patients with pre-hypertension or mild hypertension. We will also test whether Potassium Magnesium Citrate increases excretion of large amounts of sodium in the urine.

NCT ID: NCT01073189 Withdrawn - Clinical trials for Kidney Failures, Acute

Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury

IR-FTA
Start date: April 2010
Phase: Phase 4
Study type: Interventional

Randomized prospective trial of patients with diuretic unresponsive acute kidney injury where patients will receive standard supportive therapy with diuretics versus intra-renal delivery of the vasodilator fenoldopam mesylate. Patients with rising creatinine who fail to respond to bolus diuretics will be treated with a prolonged course of diuretics or undergo placement of a catheter within the renal arteries that allows for infusion of fenoldopam mesylate. The rational is that early delivery of a high dose vasodilator may reverse the decline of renal function in patients with severe acute kidney injury.

NCT ID: NCT01072370 Withdrawn - Cerebral Palsy Clinical Trials

Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children

Start date: January 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to test the safety and effectiveness of a cord blood infusion in children who have motor disability due to cerebral palsy (CP). The subjects will be children whose parents have saved their infant's cord blood, who have non-progressive motor disability, and whose parents intend to have a cord blood infusion.

NCT ID: NCT01069432 Withdrawn - Clinical trials for Chronic Lymphocytic Leukemia

Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia

Start date: May 2010
Phase:
Study type: Observational

The purpose of this study is to collect a blood sample from patients with Chronic Lymphocytic Leukemia (CLL) and from volunteers without CLL.

NCT ID: NCT01068171 Withdrawn - Clinical trials for Diabetic Foot Ulcers

Developing a Diabetic Foot Ulcer Protocol

Start date: May 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine which treatment, over 6 months, will promote healing of diabetic foot ulcers that are not infected in the most efficient, cost-effective way.

NCT ID: NCT01067677 Withdrawn - Clinical trials for Post Operative Nausea and Vomiting

Rescue Emetic Therapy for Children Having Elective Surgery

RETCHES
Start date: February 2010
Phase: N/A
Study type: Interventional

To compare ondansetron, metoclopramide, diphenhydramine, and placebo in order to determine which anti-emetic is most efficacious as a "rescue therapy" for pediatric patients ages 3-18 who have post-operative vomiting after a standardized prophylactic regimen of ondansetron and dexamethasone. We hypothesize that anti-emetics with a different mechanism of action than the prophylactic regimen will be the most effective "rescue therapy" in children having surgery in an ambulatory surgery center. 1. Problem: Despite commonly-used anti-emetics for prophylaxis, some children still go on to develop post-operative vomiting (POV). Goal: To determine which anti-emetic--ondansetron, metoclopramide, diphenhydramine, or placebo--is most efficacious for pediatric patients in this situation. 2. Hypothesis: Anti-emetic medications that have a different mechanism of action than the prophylactic regimen will be the most efficacious "rescue therapy." 3. Hypothesis: Metoclopramide at the dose of 0.5 mg/kg (max dose 20 mg) will be more effective than ondansetron, diphenhydramine, or placebo as "rescue therapy."

NCT ID: NCT01067118 Withdrawn - Diabetes Mellitus Clinical Trials

A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if the use of Linjeta(tm) insulin when compared to Humalog will result in significantly lower episodes of hyperglycemia and hypoglycemia after a breakfast meal.

NCT ID: NCT01063959 Withdrawn - Morbid Obesity Clinical Trials

Sleeve Gastrectomy Versus Gastric Bypass for Private Pay Patients Seeking Obesity Surgery

Start date: February 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine laparoscopic sleeve gastrectomy is a safer surgery than the gastric bypass, gives similar weight losses and that the safety of gastric in private pay patients versus insurance patients will be similar. This is a retrospective chart review of intervention charts.

NCT ID: NCT01063933 Withdrawn - Influenza Clinical Trials

Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

The purposes of this study are to evaluate the pharmacokinetics (affect the body has on a drug), and pharmacodynamics (affect the drug has on the body) and safety of an experimental intravenous (within a vein) flu medication, peramivir, in children. Participants will include 63 hospitalized children with confirmed flu. Children will be grouped according to age and younger children will not receive drug until safety data from the groups of older children are reviewed. Hospitalized children may receive up to 5 doses of peramivir. Study procedures include: nasal/throat swabs, reporting any experienced side effects, physical examination including assessment of the nervous system, and blood sample collection. Participants will be involved in study related procedures for up to 28 days.